Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Pharmacokinetics
Interventions
DRUG

Regorafenib (BAY73-4506); Regorafenib (BAY73-4506) plus ketoconazole

Treatment 1: A single 160 mg dose of BAY73-4506. Treatment 2: Ketoconazole 400 mg once daily from Day -4 to Day 3. A single 160 mg dose of BAY73-4506 on Day 1.

Trial Locations (1)

02135

Brighton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY